VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

VORICONAZOLE 200 MG/VIAL

MAH:

PFIZER PHARMACEUTICALS ISRAEL LTD

ATC_code:

J02AC03

pharmaceutical_form:

POWDER FOR SOLUTION FOR INFUSION

administration_route:

I.V

manufactured_by:

PFIZER PGM, FRANCE

therapeutic_group:

VORICONAZOLE

therapeutic_indication:

Treatment of : - invasive aspergillosis fluconazole-resistant serious invasive Candida infections (including C. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. Treatment of candidemia in non neutropenic patients.

authorization_date:

2012-10-01